Hainan Haiyao Stock Hits Day Low of CNY 4.59 Amid Price Pressure

Hainan Haiyao Co., Ltd. experienced a significant decline today, with the stock dropping by 6.27% and reaching an intraday low of CNY 4.59. This performance stands in contrast to the China Shanghai Composite, which saw a modest gain of 0.85% on the same day. Over the past week, Hainan Haiyao has remained flat, while the broader market index has decreased by 3.0%. In the longer term, the stock has shown a mixed performance, with a notable increase of 26.79% over the past month, yet it has struggled over the past year, declining by 27.36%. Year-to-date, the stock is down 33.15%, significantly underperforming the China Shanghai Composite, which has only decreased by 4.35%. Financial metrics indicate that Hainan Haiyao is facing challenges, including a high debt-equity ratio of 569.30 and a return on equity of -10,384.11%. The company has reported operating losses, and its net sales have contracted at an annual rate of -18.75% over the last five years. As a midcap player in the pharmaceuticals and biotechnology sector, Hainan Haiyao's current market cap stands at CNY 4,522 million.